Enanta Pharmaceuticals
Patents, Design & Utilities

Last updated:

List of all Enanta Pharmaceuticals patents 112 in total

Status Patent
Application
Utility: HEPATITIS B ANTIVIRAL AGENTS External link
Filling date: 6 Sep 2025 Issue date: 10 Dec 2020
Application
Utility: HEPATITIS B ANTIVIRAL AGENTS External link
Filling date: 6 Sep 2025 Issue date: 10 Dec 2020
Application
Utility: HEPATITIS B ANTIVIRAL AGENTS External link
Filling date: 6 Sep 2025 Issue date: 3 Dec 2020
Grant
Utility: Processes for the resolution of benzodiazepin-2-one and benzoazepin-2-one derivatives External link
Filling date: 6 Sep 2025 Issue date: 1 Dec 2020
Grant
Utility: Heterocyclic compounds as RSV inhibitors External link
Filling date: 6 Sep 2025 Issue date: 1 Dec 2020
Application
Utility: ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 19 Nov 2020
Grant
Utility: Isoxazole derivatives as FXR agonists and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 10 Nov 2020
Application
Utility: BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 5 Nov 2020
Application
Utility: APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 22 Oct 2020
Application
Utility: HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS External link
Filling date: 6 Sep 2025 Issue date: 15 Oct 2020
Application
Utility: PROCESS FOR PREPARATION OF SULFONYL CARBAMATE BILE ACID DERIVATIVES External link
Filling date: 6 Sep 2025 Issue date: 8 Oct 2020
Application
Utility: HEPATITIS B ANTIVIRAL AGENTS External link
Filling date: 6 Sep 2025 Issue date: 8 Oct 2020
Application
Utility: APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 1 Oct 2020
Application
Utility: BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS External link
Filling date: 6 Sep 2025 Issue date: 24 Sep 2020
Grant
Utility: Heterocyclic compounds as RSV inhibitors External link
Filling date: 6 Sep 2025 Issue date: 1 Sep 2020
Application
Utility: MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS External link
Filling date: 6 Sep 2025 Issue date: 27 Aug 2020
Grant
Utility: Benzimidazole derivatives External link
Filling date: 6 Sep 2025 Issue date: 25 Aug 2020
Grant
Utility: Aryldiazepine derivatives as RSV inhibitors External link
Filling date: 6 Sep 2025 Issue date: 25 Aug 2020
Grant
Utility: Hepatitis B antiviral agents External link
Filling date: 6 Sep 2025 Issue date: 11 Aug 2020
Application
Utility: PROCESS FOR PREPARATION OF SULFONYLUREA BILE ACID DERIVATIVES External link
Filling date: 6 Sep 2025 Issue date: 6 Aug 2020
Grant
Utility: Hepatitis B antiviral agents External link
Filling date: 6 Sep 2025 Issue date: 4 Aug 2020
Grant
Utility: Hepatitis B antiviral agents External link
Filling date: 6 Sep 2025 Issue date: 28 Jul 2020
Application
Utility: BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS External link
Filling date: 6 Sep 2025 Issue date: 16 Jul 2020
Grant
Utility: Hepatitis B antiviral agents External link
Filling date: 6 Sep 2025 Issue date: 7 Jul 2020
Grant
Utility: Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 30 Jun 2020
Application
Utility: HEPATITIS B ANTIVIRAL AGENTS External link
Filling date: 6 Sep 2025 Issue date: 25 Jun 2020
Grant
Utility: Isoxazole analogs as FXR agonists and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 23 Jun 2020
Grant
Utility: Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 16 Jun 2020
Grant
Utility: Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 16 Jun 2020
Grant
Utility: Process for preparation of sulfonyl carbamate bile acid derivatives External link
Filling date: 6 Sep 2025 Issue date: 9 Jun 2020
Application
Utility: FUNCTIONALIZED HETEROCYCLES AS ANTIVIRAL AGENTS External link
Filling date: 6 Sep 2025 Issue date: 28 May 2020
Application
Utility: APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 21 May 2020
Application
Utility: PROCESSES FOR THE RESOLUTION OF BENZODIAZEPIN-2-ONE AND BENZOAZEPIN-2-ONE DERIVATIVES External link
Filling date: 6 Sep 2025 Issue date: 21 May 2020
Grant
Utility: Azepin-2-one derivatives as RSV inhibitors External link
Filling date: 6 Sep 2025 Issue date: 12 May 2020
Grant
Utility: Hepatitis B antiviral agents External link
Filling date: 6 Sep 2025 Issue date: 5 May 2020
Application
Utility: BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 9 Apr 2020
Application
Utility: FUNCTIONALIZED HETEROCYCLES AS ANTIVIRAL AGENTS External link
Filling date: 6 Sep 2025 Issue date: 26 Mar 2020
Grant
Utility: Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 24 Mar 2020
Grant
Utility: Urea-containing isoxazole derivatives as FXR agonists and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 24 Mar 2020
Application
Utility: ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 12 Mar 2020
Grant
Utility: Process for preparation of sulfonylurea bile acid derivatives External link
Filling date: 6 Sep 2025 Issue date: 10 Mar 2020
Application
Utility: CYCLOALKYL-CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 27 Feb 2020
Grant
Utility: Benzodiazepine derivatives as RSV inhibitors External link
Filling date: 6 Sep 2025 Issue date: 25 Feb 2020
Grant
Utility: Hepatitis B antiviral agents External link
Filling date: 6 Sep 2025 Issue date: 21 Jan 2020
Application
Utility: NOVEL BENZIMIDAZOLE DERIVATIVES External link
Filling date: 6 Sep 2025 Issue date: 2 Jan 2020
Grant
Utility: Bile acid analogs as FXR/TGR5 agonists and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 31 Dec 2019
Grant
Utility: Processes for the resolution of benzodiazepin-2-one and benzoazepin-2-one derivatives External link
Filling date: 6 Sep 2025 Issue date: 10 Dec 2019
Grant
Utility: Bile acid derivatives as FXR agonists and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 12 Nov 2019
Application
Utility: APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 7 Nov 2019
Application
Utility: TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE THEREOF External link
Filling date: 6 Sep 2025 Issue date: 7 Nov 2019

Showing 50 to 100 of 112 patents.